HONORHEALTH JOHN C. LINCOLN MED CTR
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $9.6M
- Transactions
- 1,794
- Companies
- 40
- Average per transaction
- $5,369
Who reported the payments
| Abbott | $1,540,954 |
| Genentech, Inc. | $1,365,157 |
| Boston Scientific | $1,284,348 |
| Novartis | $687,131 |
| UCB SA | $456,257 |
| Eli Lilly | $400,105 |
| Novocure Inc. | $282,435 |
| GT Medical Technologies, Inc | $241,216 |
| Biogen | $236,380 |
| Daiichi Sankyo Inc. | $216,503 |
| Angiodynamics, Inc. | $209,167 |
| Merck | $204,345 |
| United Therapeutics Corporation | $194,592 |
| Jazz Pharmaceuticals Inc. | $190,745 |
| AbbVie | $153,024 |
| AstraZeneca | $146,660 |
| EMD Serono, Inc. | $139,389 |
| Biontech SE | $137,492 |
| Ipsen Innovation | $118,279 |
| Ipsen Pharma SAS | $112,759 |
| Genmab U.S., Inc. | $112,164 |
| Impulse Dynamics (USA) Inc. | $110,237 |
| Stryker | $108,145 |
| CSL Behring | $104,042 |
| Edwards Lifesciences | $82,991 |
| F. Hoffmann-la Roche AG | $65,313 |
| Centerline Biomedical Inc. | $63,771 |
| Hoffmann-la Roche Limited | $51,411 |
| Janssen Research & Development, LLC | $34,874 |
| Siemens Medical Solutions USA, Inc. | $33,677 |
| Clovis Oncology, Inc. | $32,338 |
| Ipsen Bioscience Inc. | $32,189 |
| Beigene, Ltd. | $31,331 |
| Iovance Biotherapeutics, Inc. | $30,000 |
| Microport Orthopedics Inc | $29,783 |
| Procyrion, Inc. | $29,429 |
| Shockwave Medical, Inc | $28,276 |
| National Marrow Donor Program | $24,856 |
| Smith+Nephew | $23,985 |
| Beigene USA, Inc. | $23,630 |